Skip to content
10-K

Annual Report

RenovoRx, Inc. RNXT

0001193125-26-131928

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 35.33M sh
Shares Diluted FY 2025 · Dec 31, 2024 22.27M sh
Capex FY 2025 · Dec 31, 2025 $2K
Capex FY 2025 · Dec 31, 2024 $12K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$10.97M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$9.13M
Cash And Equivalents FY 2025 · Dec 31, 2025 $7.02M
Cash And Equivalents FY 2025 · Dec 31, 2024 $7.15M
Stockholders Equity FY 2025 · Dec 31, 2025 $5.42M
Stockholders Equity FY 2025 · Dec 31, 2024 $4.48M
Stockholders Equity restated FY 2025 · Dec 31, 2023 $3M
Current Liabilities FY 2025 · Dec 31, 2025 $1.96M
Current Liabilities FY 2025 · Dec 31, 2024 $1.91M
Total Liabilities FY 2025 · Dec 31, 2025 $2.67M
Total Liabilities FY 2025 · Dec 31, 2024 $3.64M
Current Assets FY 2025 · Dec 31, 2025 $7.89M
Current Assets FY 2025 · Dec 31, 2024 $7.83M
Total Assets FY 2025 · Dec 31, 2025 $8.1M
Total Assets FY 2025 · Dec 31, 2024 $8.12M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.32
Eps Diluted FY 2025 · Dec 31, 2024 −$0.40
Eps Basic FY 2025 · Dec 31, 2025 −$0.32
Eps Basic FY 2025 · Dec 31, 2024 −$0.40
Sga Expense FY 2025 · Dec 31, 2025 $7.04M
Sga Expense FY 2025 · Dec 31, 2024 $4.99M
Rd Expense FY 2025 · Dec 31, 2025 $6.27M
Rd Expense FY 2025 · Dec 31, 2024 $6.03M
Net Income FY 2025 · Dec 31, 2025 −$11.17M
Net Income FY 2025 · Dec 31, 2024 −$8.81M
Operating Income FY 2025 · Dec 31, 2025 −$12.51M
Operating Income FY 2025 · Dec 31, 2024 −$10.97M
Gross Profit FY 2025 · Dec 31, 2025 $796K
Gross Profit FY 2025 · Dec 31, 2024 $43K
Cost Of Revenue FY 2025 · Dec 31, 2025 $327K
Cost Of Revenue FY 2025 · Dec 31, 2024 $0
Revenue FY 2025 · Dec 31, 2025 $1.12M
Revenue FY 2025 · Dec 31, 2024 $43K